These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19212879)

  • 1. Multivariate dose response test.
    Tsai KT; Peace KE
    J Biopharm Stat; 2009; 19(2):273-9. PubMed ID: 19212879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing onset in psychopharmacological clinical trials.
    Laska EM; Siegel C
    Psychopharmacol Bull; 1995; 31(1):29-35. PubMed ID: 7675985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical factors that may confound the assessment of drug efficacy.
    Csernansky JG; Newcomer JW; Miller LS; Faustman WO
    Psychopharmacol Bull; 1991; 27(3):231-5. PubMed ID: 1775593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis for two-stage seamless design with different study endpoints.
    Chow SC; Lu Q; Tse SK
    J Biopharm Stat; 2007; 17(6):1163-76. PubMed ID: 18027223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in medication clinical trials.
    Rudorfer MV
    Psychopharmacol Bull; 1993; 29(1):35-44. PubMed ID: 8378510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an alternative to the randomized controlled trial?
    Leber P
    Psychopharmacol Bull; 1991; 27(1):3-8. PubMed ID: 1862203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional and alternative research designs and methods in clinical pediatric psychopharmacology.
    Fava M
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1292-303. PubMed ID: 8885583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems of drug treatment of mental disorders.
    Vartanian FE
    Adv Biochem Psychopharmacol; 1980; 24():603-7. PubMed ID: 6996446
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring symptom response to pharmacological interventions in patients with COPD: a review of instruments used in clinical trials.
    Jadad A; Rizo C; Cubillos P; Ståhl E
    Curr Med Res Opin; 2004 Dec; 20(12):1993-2005. PubMed ID: 15701216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trussed in evidence? Ambiguities at the interface between clinical evidence and clinical practice.
    Healy D
    Transcult Psychiatry; 2009 Mar; 46(1):16-37. PubMed ID: 19293278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difficulties of a clinician in planning psychopharmacological trials (author's transl)].
    Woggon B
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):140-6. PubMed ID: 360238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designs for phase I clinical trials with multiple courses of subjects at different doses.
    Fan SK; Wang YG
    Biometrics; 2007 Sep; 63(3):856-64. PubMed ID: 17403103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate time-to-event analysis of multiple adverse events of drugs in integrated analyses.
    Güttner A; Kübler J; Pigeot I
    Stat Med; 2007 Mar; 26(7):1518-31. PubMed ID: 16903003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.